Building access to the Regenstrief Institute is currently restricted. More on our coronavirus precautions.
See our coronavirus precautions.

LOINC® Executive Director Marjorie Rallins, DPM, M.S., participated in a panel discussion during the Office of the National Coordinator for Health Information Technology (ONC) 2021 annual meeting. More than 1,000 health information technology partners signed up to attend the two-day virtual event 

Dr. Rallins was on a panel called Meeting Data Modernization Needs: Standards Development Organizations Rise to the Challenge. She and other experts discussed how standards development organizations such as LOINC address data modernization needs such as accelerated content development to address largescale events like the COVID-19 pandemic while maintaining the features and services necessary to meet the growing requirements for interoperability. 

Dr. Rallins outlined how healthcare draws upon new sources of data such as social determinants of health that enhance the ability of care teams to stand the social factors that impact health and health careShe highlighted LOINC’s model for representing measures of social determinants of health in a uniform and consistent way to support interoperability of data.  

LOINC, the acronym for Logical Observation Identifiers Names and Codes, is used by healthcare systems, health-related organizations, public health officials and others in nearly every country around the globe to uniformly identify medical tests, laboratory results, health observations and more, allowing this data to be accurately collected and exchanged. With long-term funding support from U.S. federal agencies and other organizations, LOINC is available free of charge. 

About LOINC®

LOINC was created in 1994 at Regenstrief Institute to facilitate interoperability in healthcare. There was a growing trend to send clinical data electronically between healthcare entities, a practice that has now become ubiquitous. Today, it contains almost 95,000 terms for everything from a serum alpha 1 antitrypsin level to a zygomatic arch x-ray report. For each concept, LOINC contains many other rich details, such as synonyms, units of measure, and carefully crafted descriptions. 

About Regenstrief Institute

Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its research scientists are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform practice and improve the lives of patients around the globe. 

Sam Regenstrief, a nationally successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission. 

MEDIA CONTACTS:
John Erickson
Regenstrief Institute
prteam@regenstrief.org
(317) 643-2313

Related News

Jul 28, 2021 • News
Foundation of trust needed to have successful shared decision-making on pain treatment 
Editorial examines complexities of relationships and communication   A foundation of trust is crucial to help patients with chronic pain have productive conversations about pain management with their clinicians as well as better overall health outcomes, especially when it comes to opioids, according to a viewpoint article in the Journal of General Internal Medicine written by authors from Regenstrief Institute, the U.S. Department of Veterans Affairs and…
Continue Reading >
Jul 26, 2021 • News
Media coverage of health, especially disease screening, is often not sufficiently nuanced
The media covers health extensively, at no time more than during the pandemic. But that coverage often is not sufficiently nuanced. In a JAMA Internal Medicine commentary focusing on media coverage of disease screening, Regenstrief Institute Vice President and Indiana University School of Medicine Associate Dean Aaron E. Carroll, M.D., and IU School of Medicine…
Continue Reading >